Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04849585

Acronym

POSTREACOVID

Enrollment

Registered

2021-04-19

Start date

2022-06-30

Completion date

2023-02-28

Last updated

2022-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

To evaluate the psychological, physical, social, professional and family impact of a hospitalization in intensive care for a covid 19 by analysis of the verbatim during a semi-structured interview.

Interventions

OTHERsemi-directed entretien

semi-directed entretien

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* All patients hospitalized in intensive care at CH Dron for a COVID 19 who have given their agreement during their follow-up consultation

Exclusion criteria

* Minor patient * Patient does not speak French * Refusal to participate

Design outcomes

Primary

Measure	Time frame	Description
Psychological impact of hospitalization in intensive care for a covid 19.	At day 1	Frequency of recurring nightmares, irritability and anxious patient
Physical impact of hospitalization in intensive care for a covid 19.	At day 1	Frequency of Handicap and resumption of professional and personal activities

Countries

France

Contacts

Primary ContactPauline THILL, MD

pthill@ch-tourcoing.fr0320694949

Backup ContactSolange TREHOUX, PhD

strehoux@ch-tourcoing.fr0320694280

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026